Strategic Partnerships Nexalin is advancing its HALO Clarity platform and NeuroCare AI-driven virtual clinic, signaling opportunities to partner with healthcare providers, clinics, and long-term care facilities seeking non-invasive neurotherapy solutions and remote patient management.

Clinical Expansion Recent collaborations with UC San Diego for at-home mild traumatic brain injury trials and ongoing CNS-related programs indicate a pathway to engage hospitals and research centers for joint studies, pilot programs, and reimbursement discussions.

Executive Visibility New leadership additions including a CFO and high-profile advisory board members (retired general Wesley Clark) enhance credibility for capital raises, government contracts, and strategic collaborations with military, veterans, and public health programs.

Regulatory Positioning FDA classification as a low-risk device with clinical trial suitability supports conversations with payers and clinics about non-invasive treatment options for anxiety, depression, insomnia, Alzheimer's, mood disorders, TBI and PTSD.

Global Market Potential Small revenue scale but substantial funding and global tech stack readiness point to scalable deployments through enterprise clinics, sleep centers, neurology practices, and telehealth-enabled neurotherapy offerings.